risk of medullary thyroid cancer with glp 1 GLP-1 Receptor Agonists and Risk, Rodent Data and FDA Warning, • In rodents, GLP-1 receptor agonists (GLP-1 RAs) stimulate thyroid C-cells, increasing the incidence thyroid Glucagon-like peptide 1 receptor agonists

kidney routes), their excretion, their elimination half-life, their target selectivity, and their effective dosage [46]

I hope this helps

While anecdotal reports suggest GLP-1 drugs may reduce alcohol consumption, a Novo Nordisk spokesperson said a phase 2 trial will be studying semaglutide the active ingredient in Wegovy and Ozempic and related compounds for their effects on alcohol-related liver disease, with drinking habits monitored as a secondary outcome

Importantly, exenatide did not significantly alter withdrawal thresholds in contralateral paws [24]

Previous studies of the weight-loss drug semaglutide hinted that people using either Ozempic or Wegovy had less troublesome alcohol cravings

reduction in gastric emptying32 (Fig